XML 25 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Oct. 28, 2023
Oct. 29, 2022
Operating activities    
Net income (loss) $ 39,735 $ (15,018)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:    
Depreciation and amortization 15,387 32,275
Loss from equity method investments 1,414 1,773
Loss on deconsolidation of previously controlled subsidiary   189
Amortization of debt issuance costs 424 422
Provision for doubtful accounts 4 19
Reserve for inventory excess and obsolescence 8,338 2,859
Other non-cash expense, net 331 565
Non-cash lease expense 4,486 3,775
Gain on foreign currency transactions (184) (59)
Unrealized loss (gain) on available-for-sale equity securities, net 3,463 (928)
Deferred income taxes (1,006) (808)
Stock-based compensation 8,244 4,402
Loss on disposal of property and equipment 136 825
Amortization of debt securities discount   125
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 15,553 28,012
Unbilled receivables and retentions (35,175) 11,696
Inventories (49,329) (26,695)
Income taxes receivable (5,735) (8,539)
Prepaid expenses and other assets (12,720) (1,117)
Accounts payable (6,105) 6,823
Other liabilities (12,851) (8,664)
Net cash (used in) provided by operating activities (25,590) 31,932
Investing activities    
Acquisition of property and equipment (10,104) (7,587)
Equity method investments (1,875) (2,774)
Equity security investments   (5,100)
Acquisitions of intangible assets (1,500)  
Business acquisitions, net of cash acquired (24,156) (5,105)
Proceeds from deconsolidation of previously controlled subsidiary, net of cash deconsolidated   (635)
Redemptions of available-for-sale investments   25,945
Purchases of available-for-sale investments   (1,326)
Net cash (used in) provided by investing activities (37,635) 3,418
Financing activities    
Principal payments of term loan (55,000) (22,500)
Holdback and retention payments for business acquisition (500)  
Proceeds from shares issued, net of issuance costs 88,437 11,778
Payment of debt issuance costs (8)  
Tax withholding payment related to net settlement of equity awards (1,370) (853)
Exercise of stock options   682
Other (15) (14)
Net cash provided by (used in) financing activities 31,544 (10,907)
Effects of currency translation on cash and cash equivalents (270) (257)
Net (decrease) increase in cash, cash equivalents, and restricted cash (31,951) 24,186
Cash, cash equivalents and restricted cash at beginning of period 132,859 77,231
Cash, cash equivalents and restricted cash at end of period 100,908 101,417
Cash paid, net during the period for:    
Income taxes 11,054 718
Interest 4,818 3,398
Non-cash activities    
Unrealized gain on available-for-sale investments, net of deferred tax expense of $0 for the six months ended October 28, 2023 and October 29, 2022, respectively   (26)
Issuance of common stock for business acquisition 109,820  
Change in foreign currency translation adjustments (1,625) (1,992)
Issuances of inventory to property and equipment, ISR in-service assets   4,085
Acquisitions of property and equipment included in accounts payable $ 915 $ 810